Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    22377126 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.
Condition: Breast Cancer
Interventions: Drug: Standard chemotherapy;   Drug: bevacizumab [Avastin];   Drug: trastuzumab [Herceptin]

Study has passed its completion date and status has not been verified in more than two years.